Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
Sylene C.R. Carvalho; Luydson R.S. Vasconcelos; Leonardo da Fonseca; Rodrigo F. Carmo; Michele T. Tomitão; Dayse C.B.L. Aroucha; Leila M.M.B. Pereira; José Tadeu Stefano; Ulysses Ribeiro-Júnior; Claudia P. Oliveira; Flair J. Carrilho;
Clinics. 2021;76C:
SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma
Ying Liu; Taoying Chen; Li Tang; Daqing Cheng; Ming Xu; Jiaoxiang Wu; Bingyan Liu; Hao Cheng; Bo Han; Yu Zhang; Sheng Cheng;
10.1016/j.clinsp.2025.100796
The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis
Claudia Maccali; Isabel Veloso Alves Pereira; Lisa Rodrigues da Cunha Saud; Regiane Saraiva de Souza Melo Alencar; Arthur Ivan Nobre Oliveira; Jose Tadeu Stefano; Michele Soares Gomes Gouvea; Joyce Matie Kinoshita da Silva Etto; Paulo Herman; João Renato Rebello Pinho; Rafael Soares Nunes Pinheiro; Wellington Andraus; Luiz Augusto Carneiro D¿Albuquerque; Mario Guimarães Pessoa; Aline Lopes Chagas; Claudia Pinto Marques Souza de Oliveira;
10.1016/j.clinsp.2025.100797